Skip to main content

Advertisement

SpringerLink
Log in

Bladder Cancer Diagnosis and Treatment for Patients with Neurogenic Bladder: Does the Literature Support a Different Approach?

  • REVIEW
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

In this review, the current literature available to patients and providers on the diagnosis and management of bladder cancer in patients with neurogenic bladder will be discussed. Topics include bladder cancer epidemiology in the neurogenic population and unique features of this tumor in this subset of patients, current screening recommendations, and differences in the treatment for this patient population, outlining specific changes in the surgical approach.

Recent Findings

Neurogenic lower urinary tract dysfunction (NLUTD) patients are living longer due to better care, and cancer is becoming more frequent. This is partly due to the aging of this population, as well as intrinsic factors related to the underlying condition or urinary diversion, which poses a greater risk of developing genitourinary malignancies. There are multiple studies published that have investigated this specific patient population, most derived from large cohorts of patients with spinal cord injury.

Summary

Although there is more evidence on screening for bladder cancer, specific screening protocols for different underlying conditions and urinary diversion are lacking. Few studies have looked prospectively into the management of bladder cancer in this subset of patients, and good quality evidence for tailoring the care of this population is lacking. Nonetheless, surgical complications are expected to be greater in this scenario.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Reproduced with permission from Böthig

Similar content being viewed by others

Data Availability

No datasets were generated or analysed during the current study.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Hartkopp A, et al. Survival and cause of death after traumatic spinal cord injury. A long-term epidemiological survey from Denmark. Spinal Cord. 1997;35(2):76–85.

    Article  CAS  PubMed  Google Scholar 

  2. Brandes SB, et al. Renal cell carcinoma in patients with prior spinal cord injury. J Spinal Cord Med. 2001;24(4):251–6.

    Article  CAS  PubMed  Google Scholar 

  3. • Ismail S, et al. Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: a systematic review. Neurourol Urodyn. 2018;37(4):1386–95. (Systematic review on prevalence and mortality of bladder cancer in NGB population.)

    Article  PubMed  Google Scholar 

  4. Nahm LS, et al. Bladder cancer mortality after spinal cord injury over 4 decades. J Urol. 2015;193(6):1923–8.

    Article  PubMed  Google Scholar 

  5. Siegel RL, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48.

    Article  PubMed  Google Scholar 

  6. •• Liu B, Welk B. Urological malignancies in neurogenic patients. Curr Opin Urol. 2020;30(4):501–6. (Review article, overview of urologic malignancies in patients with NGB, mostly focused on prostate and bladder cancer. The review showed a lower incidence of bladder cancer in the NLUTD population than previously found.)

    Article  CAS  PubMed  Google Scholar 

  7. Welk B, et al. Bladder cancer in individuals with spinal cord injuries. Spinal Cord. 2013;51(7):516–21.

    Article  CAS  PubMed  Google Scholar 

  8. • Prattley S, New F, Davies M. Malignancies of suprapubic catheter (SPC) tracts in spinal cord injury patients: a case series and review of literature. Spinal Cord Ser Cases. 2019;5:34. https://doi.org/10.1038/s41394-019-0177-9. (Authors presented the first case series of malignancy of the SPC tract in SCI patients.)

  9. •• Bothig R, et al. Clinical characteristics of bladder cancer in patients with spinal cord injury: the experience from a single centre. Int Urol Nephrol. 2017;49(6):983–94. (Single-centre retrospective evaluation of patient data with spinal cord injuries and proven urinary bladder cancer and summary of the literature. The authors found that younger age at onset and the frequency of invasive tumours at diagnosis indicate that spinal cord injury influences bladder cancer risk and prognosis.)

    Article  PubMed  Google Scholar 

  10. Gui-Zhong L, Li-Bo M. Bladder cancer in individuals with spinal cord injuries: a meta-analysis. Spinal Cord. 2017;55(4):341–5.

    Article  CAS  PubMed  Google Scholar 

  11. Rove KO, et al. Systematic review of bladder cancer outcomes in patients with spina bifida. J Pediatr Urol. 2017;13(5):456 e1-456 e9.

    Article  PubMed  Google Scholar 

  12. De Ridder D, et al. Bladder cancer in patients with multiple sclerosis treated with cyclophosphamide. J Urol. 1998;159(6):1881–4.

    Article  PubMed  Google Scholar 

  13. Lebrun C, et al. Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis. Mult Scler. 2008;14(3):399–405.

    Article  PubMed  Google Scholar 

  14. Marrie RA, et al. A systematic review of the incidence and prevalence of cancer in multiple sclerosis. Mult Scler. 2015;21(3):294–304.

    Article  PubMed  PubMed Central  Google Scholar 

  15. • Marrie RA, et al. Cancer incidence and mortality rates in multiple sclerosis: a matched cohort study. Neurology. 2021;96(4):e501–12. (The authors found that the incidence of breast and colorectal cancers does not differ between persons with and without MS; however, the incidence of bladder cancer is increased. Overview of bladder cancer incidence and mortality among patients with Multiple Sclerosis.)

    Article  CAS  PubMed  Google Scholar 

  16. Grytten N, et al. Incidence of cancer in multiple sclerosis before and after the treatment era- a registry- based cohort study. Mult Scler Relat Disord. 2021;55:103209.

    Article  CAS  PubMed  Google Scholar 

  17. Ho CH, et al. Chronic indwelling urinary catheter increase the risk of bladder cancer, even in patients without spinal cord injury. Medicine (Baltimore). 2015;94(43):e1736.

    Article  PubMed  Google Scholar 

  18. Cameron AP, Rodriguez GM, Schomer KG. Systematic review of urological followup after spinal cord injury. J Urol. 2012;187(2):391–7.

    Article  PubMed  Google Scholar 

  19. Taweel WA, Seyam R. Neurogenic bladder in spinal cord injury patients. Res Rep Urol. 2015;7:85–99.

    PubMed  PubMed Central  Google Scholar 

  20. Stonehill WH, et al. Risk factors for bladder tumors in spinal cord injury patients. J Urol. 1996;155(4):1248–50.

    Article  CAS  PubMed  Google Scholar 

  21. Pannek J. Transitional cell carcinoma in patients with spinal cord injury: a high risk malignancy? Urology. 2002;59(2):240–4.

    Article  PubMed  Google Scholar 

  22. Biardeau X, et al. Risk of malignancy after augmentation cystoplasty: a systematic review. Neurourol Urodyn. 2016;35(6):675–82.

    Article  PubMed  Google Scholar 

  23. Hoen L, et al. Long-term effectiveness and complication rates of bladder augmentation in patients with neurogenic bladder dysfunction: a systematic review. Neurourol Urodyn. 2017;36(7):1685–702.

    Article  PubMed  Google Scholar 

  24. Groah SL, et al. Excess risk of bladder cancer in spinal cord injury: evidence for an association between indwelling catheter use and bladder cancer. Arch Phys Med Rehabil. 2002;83(3):346–51.

    Article  PubMed  Google Scholar 

  25. Esrig D, McEvoy K, Bennett CJ. Bladder cancer in the spinal cord-injured patient with long-term catheterization: a casual relationship? Semin Urol. 1992;10(2):102–8.

    CAS  PubMed  Google Scholar 

  26. Hamid R, et al. Epidemiology and pathophysiology of neurogenic bladder after spinal cord injury. World J Urol. 2018;36(10):1517–27.

    Article  PubMed  Google Scholar 

  27. •• Bothig R, et al. Traumatic spinal cord injury confers bladder cancer risk to patients managed without permanent urinary catheterization: lessons from a comparison of clinical data with the national database. World J Urol. 2020;38(11):2827–34. (Single-centre retrospective evaluation of consecutive in- and out-patient data with spinal cord injury, focusing on bladder cancer risks in the neurogenic bladder population. The author found that in patients with SCI bladder management even without permanent catheterization represents a considerable risk for the development of bladder tumors.)

    Article  PubMed  Google Scholar 

  28. Ginsberg DA, et al. The AUA/SUFU guideline on adult neurogenic lower urinary tract dysfunction: treatment and follow-up. J Urol. 2021;206(5):1106–13.

    Article  PubMed  Google Scholar 

  29. Ginsberg DA, et al. The AUA/SUFU guideline on adult neurogenic lower urinary tract dysfunction: diagnosis and evaluation. J Urol. 2021;206(5):1097–105.

    Article  PubMed  Google Scholar 

  30. El Masri y WS, et al. To cystoscope or not to cystoscope patients with traumatic spinal cord injuries managed with indwelling urethral or suprapubic catheters? That is the question! Spinal Cord. 2014;52(1):49–53.

    Article  PubMed  Google Scholar 

  31. Hamid R, et al. Screening cystoscopy and biopsy in patients with neuropathic bladder and chronic suprapubic indwelling catheters: is it valid? J Urol. 2003;170(2 Pt 1):425–7.

    Article  CAS  PubMed  Google Scholar 

  32. Hamid R, et al. Routine surveillance cystoscopy for patients with augmentation and substitution cystoplasty for benign urological conditions: is it necessary? BJU Int. 2009;104(3):392–5.

    Article  PubMed  Google Scholar 

  33. Fitzpatrick R, Baverstock R. Muscle invasive bladder cancer presenting as recurrent autonomic dysreflexia - a wolf in wolf’s clothing. J Spinal Cord Med. 2020;43(4):540–3.

    Article  PubMed  Google Scholar 

  34. Davis M. When guidelines conflict: patient safety, quality of life, and CAUTI reduction in patients with spinal cord injury. Spinal Cord Ser Cases. 2019;5:56.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Lewis J, et al. A framework for transitioning patients from pediatric to adult health settings for patients with neurogenic bladder. Neurourol Urodyn. 2017;36(4):973–8.

    Article  PubMed  Google Scholar 

  36. Flaig TW, et al. NCCN guidelines(R) insights: bladder cancer, version 2.2022. J Natl Compr Canc Netw. 2022;20(8):866–78.

    Article  PubMed  Google Scholar 

  37. Necchi A, et al. Updated results of PURE-01 with preliminary activity of neoadjuvant pembrolizumab in patients with muscle-invasive bladder carcinoma with variant histologies. Eur Urol. 2020;77(4):439–46.

    Article  CAS  PubMed  Google Scholar 

  38. Song Y, Xu T. Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder. World J Urol. 2023;41(6):1697–8.

    Article  PubMed  Google Scholar 

  39. Delnay KM, et al. Bladder histological changes associated with chronic indwelling urinary catheter. J Urol. 1999;161(4):1106–8 (discussion 1108-9).

    Article  CAS  PubMed  Google Scholar 

  40. • Sampogna G, et al. Experience of a tertiary referral center in managing bladder cancer in conjunction with neurogenic bladder. Spinal Cord Ser Cases. 2020;6(1):61. (Single-center retrospective analysis with pre, intra and post operative data for NB with BCa. The authors found that BCa in individuals with NB is associated with a diagnosis at an advanced stage and a high rate of surgical complications.)

    Article  PubMed  PubMed Central  Google Scholar 

  41. McMichan JC, Michel L, Westbrook PR. Pulmonary dysfunction following traumatic quadriplegia. Recognition, prevention, and treatment. JAMA. 1980;243(6):528–31.

    Article  CAS  PubMed  Google Scholar 

  42. Singh G, Thomas DG. Bowel problems after enterocystoplasty. Br J Urol. 1997;79(3):328–32.

    Article  CAS  PubMed  Google Scholar 

  43. Shimko MS, et al. Long-term complications of conduit urinary diversion. J Urol. 2011;185(2):562–7.

    Article  PubMed  Google Scholar 

  44. •• Bothig R, et al. Special surgical aspects of radical cystectomy in spinal cord injury patients with bladder cancer. World J Urol. 2022;40(8):1961–70. (Single-center retrospective analysis with pre, intra and post operative data for NB with BCa. Very useful management considerations for pre, intra and post operative steps to avoid complication, based on authors` expertise.)

    Article  PubMed  Google Scholar 

  45. Cheng JN, et al. Cystectomy in patients with spinal cord injury: indications and long-term outcomes. J Urol. 2010;184(1):92–8.

    Article  PubMed  Google Scholar 

  46. Guillot-Tantay C, et al. Complications of non-continent cutaneous urinary diversion in adults with spinal cord injury: a retrospective study. Spinal Cord. 2018;56(9):856–62.

    Article  PubMed  Google Scholar 

  47. Meléndez, Mar et al. Bladder cancer in patients with spina bifida: observation from an adult clinic. Spinal Cord Ser Cases. 2018;4:27. https://www.nature.com/articles/s41394-018-0066-7.

Download references

Funding

No funding was received for this article.

Author information

Authors and Affiliations

  1. Department of Urology, University of Wisconsin – Madison, Madison, WI, USA

    M. P. Bigarella & K. A. Richards

Authors
  1. M. P. Bigarella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. A. Richards
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MB wrote the main manuscript text.

KR provided the outline for the manuscript and the relevance of each topic.

MB and KR reviewed the manuscript.

Corresponding author

Correspondence to M. P. Bigarella.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bigarella, M.P., Richards, K.A. Bladder Cancer Diagnosis and Treatment for Patients with Neurogenic Bladder: Does the Literature Support a Different Approach?. Curr Bladder Dysfunct Rep (2024). https://doi.org/10.1007/s11884-024-00747-5

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11884-024-00747-5

Keywords

Search

Navigation